PAGLIARO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 1.276
AS - Asia 1.226
EU - Europa 1.069
SA - Sud America 209
AF - Africa 73
OC - Oceania 2
Totale 3.855
Nazione #
US - Stati Uniti d'America 1.218
IT - Italia 587
SG - Singapore 413
VN - Vietnam 260
CN - Cina 232
BR - Brasile 150
DE - Germania 89
HK - Hong Kong 89
BD - Bangladesh 72
FR - Francia 62
NL - Olanda 50
ZA - Sudafrica 45
RU - Federazione Russa 43
IE - Irlanda 40
AT - Austria 39
FI - Finlandia 36
IN - India 33
GB - Regno Unito 32
CA - Canada 31
SE - Svezia 26
AR - Argentina 24
IQ - Iraq 19
MX - Messico 17
KR - Corea 14
ID - Indonesia 13
JP - Giappone 13
PL - Polonia 13
BE - Belgio 10
TR - Turchia 10
PK - Pakistan 9
CZ - Repubblica Ceca 8
PH - Filippine 8
EC - Ecuador 7
LT - Lituania 7
UA - Ucraina 7
EG - Egitto 6
ES - Italia 6
PA - Panama 6
CO - Colombia 5
MA - Marocco 5
PY - Paraguay 5
SA - Arabia Saudita 5
UY - Uruguay 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
IL - Israele 4
PE - Perù 4
TH - Thailandia 4
UZ - Uzbekistan 4
VE - Venezuela 4
DZ - Algeria 3
GR - Grecia 3
KE - Kenya 3
MY - Malesia 3
PT - Portogallo 3
TW - Taiwan 3
AU - Australia 2
CL - Cile 2
HR - Croazia 2
LY - Libia 2
NI - Nicaragua 2
NP - Nepal 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BO - Bolivia 1
CY - Cipro 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
RO - Romania 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TN - Tunisia 1
Totale 3.855
Città #
Ashburn 264
Singapore 242
Parma 159
San Jose 147
Dallas 124
Santa Clara 88
Hong Kong 84
Ho Chi Minh City 82
Boardman 70
Milan 56
Hanoi 50
New York 47
Beijing 45
Johannesburg 42
Munich 42
Dublin 40
Los Angeles 38
Bologna 37
Ann Arbor 33
Vienna 33
Lauterbourg 30
Chandler 27
Shanghai 26
São Paulo 24
Rome 22
Chicago 21
Buffalo 20
Reggio Emilia 20
Turku 20
Hefei 19
Brescia 17
Haiphong 17
Modena 17
Moscow 17
Nuremberg 14
Toronto 13
Frankfurt am Main 12
Helsinki 12
Amsterdam 11
Council Bluffs 11
Biên Hòa 10
Jakarta 10
Brooklyn 9
Montreal 9
Seoul 9
Tokyo 9
Warsaw 9
Brussels 8
Carpi 8
Curitiba 8
Fidenza 8
Perugia 8
West Jordan 8
Baghdad 7
London 7
Turin 7
Columbus 6
Orem 6
Rio de Janeiro 6
Boston 5
Chandigarh 5
Da Nang 5
Denver 5
Florence 5
Lahore 5
Mexico City 5
Naples 5
Poplar 5
San Francisco 5
Abidjan 4
Atlanta 4
Baku 4
Brasília 4
Bremen 4
Brno 4
Cairo 4
Charlotte 4
Chennai 4
Concesio 4
Istanbul 4
Nanjing 4
Paris 4
Phoenix 4
Princeton 4
Querétaro 4
Quito 4
Roubaix 4
Salvador 4
Seattle 4
Tashkent 4
Bengaluru 3
Buenos Aires 3
Cape Town 3
Casalgrande 3
City of London 3
Guangzhou 3
Houston 3
Inglewood 3
Jeddah 3
Kochi 3
Totale 2.409
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 256
Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line 251
Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis 229
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 228
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 208
Targeting oncogenic Notch signaling with SERCA inhibitors 187
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 162
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 155
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 153
Targeting Notch Trafficking and Processing in Cancers 147
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 144
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 138
Acute lymphoblastic leukaemia 135
SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL 135
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 130
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 129
Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia 118
PROGNOSTIC VALUE OF CYTOGENETIC ABERRATIONS AND INTRATUMORAL GENETIC HETEROGENEITY IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) 113
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 105
T(10;11)(P13;P14-21) PICALM-MLLT10 ACUTE LEUKEMIA: CHARACTERIZATION OF TWO CASES WITH DIFFERENT PHENOTYPIC PRESENTATION 98
FROM GENOMICS TO CHEMOGEGNOMICS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA 95
Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine 94
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 90
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 81
Ex-vivo drug response profiling guides therapy in a case of high-risk acute undifferentiated leukemia with PICALM::MLLT10 73
A chemotrascriptomic screening identifies the reversal of glucocorticoid resistance in NOTCH1 mutated T-ALL. 70
Nidogen-1, a Player in KMT2A-Rearranged Pediatric Acute Myeloid Leukemia 64
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 52
Targeting oncogenic NOTCH1 in T-cell acute lymphoblastic leukemia with a new selective serca inhibitor. 44
Drug profiling in a preclinical murine mantle cell lymphoma mouse model identifies novel vulnerabilities. 43
Targeting Oncogenic NOTCH1 in T-cell Acute Lymphoblastic Leukemia With a Selective SERCA Inhibitor CAD204520 2
Totale 3.929
Categoria #
all - tutte 12.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/202251 3 4 6 4 3 4 11 3 1 3 2 7
2022/2023166 8 19 12 11 31 14 5 7 36 2 17 4
2023/2024259 8 3 4 15 5 18 70 22 14 33 17 50
2024/2025956 33 37 55 81 84 73 77 71 105 71 98 171
2025/20262.378 192 137 271 271 313 148 180 150 307 205 111 93
Totale 3.929